Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Health Consequences of the Burden of Atrial Fibrillation - The Swiss-AF-BURDEN Study

NCT05389228 is registered in ClinicalTrials.gov with University Hospital, Basel, Switzerland as lead sponsor.

NCT NCT05389228
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05389228 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Health Consequences of the Burden of Atrial Fibrillation - The Swiss-AF-BURDEN Study
Lead sponsor
University Hospital, Basel, Switzerland
Phase
Observational
Overall status
Completed
Start date
August 1, 2018
Completion date
January 7, 2024
Enrollment
325 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

atrial fibrillation, burden